Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Q4 2020 Earnings Conference Call March 1, 2021 4:30 PM ET Company Participants Neda Safarzadeh - Head-Investor Relations, Public Relations & Marketing Joseph Payne - President & Chief Executive Officer Ooi Eng Eong - Deputy Director-Emerging Infectious Diseases Programme-Duke-NUS Medical School & Arcturus Vaccine Platform Scientific-Advisory Board Steve Hughes - Chief Medical Officer Andy Sassine - Chief Financial Officer Pad Chivukula - Chief Scientific Off ...

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Q3 2020 Results Earnings Conference Call November 9, 2020 4:30 PM ET Company Participants Neda Safarzadeh - Head of Investor Relations, Public Relations & Marketing Joseph Payne - President & Chief Executive Officer Andy Sassine - Chief Financial Officer Steve Hughes - Chief Development Officer Conference Call Participants Seamus Fernandez - Guggenheim Madhu Kumar - Baird Yasmeen Rahimi - Piper Sandler Yigal Nochomovitz - Citigroup Steve Seedhouse - Raymond ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 Common Stock, par value $0.001 per share ARCT The Nasdaq Stock Market LLC FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-38942 | --- | --- | |------------------------------ ...

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Q2 2020 Earnings Conference Call August 10, 2020 4:30 PM ET Company Participants Neda Safarzadeh - Head of Investor Relations, Public Relations & Marketing Joseph Payne - President & Chief Executive Officer Andy Sassine - Chief Financial Officer Steve Hughes - Chief Development Officer Conference Call Participants Seamus Fernandez - Guggenheim Madhu Kumar - Baird and Company Wangzhi Li - Ladenburg Ryan Deschner - Raymond James Justin Zelin - B. Riley Securit ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 Common Stock, par value $0.001 per share ARCT The NASDAQ Stock Market LLC FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-38942 | --- | --- | |----------------------------------- ...

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Q1 2020 Earnings Conference Call May 7, 2020 4:30 PM ET Company Participants Neda Safarzadeh – Head-Investor Relations Joseph Payne – president and Chief Executive Officer Andy Sassine – Chief Financial Officer Pad Chivukula – Chief Scientific Officer and Chief Operating Officer Steve Hughes – Chief Development Officer Conference Call Participants Whitney Ijem – Guggenheim Jennifer Teubl – R.W. Baird Paul O’Brien – ROTH Capital Thomas Yip – H.C. Wainwright K ...